OnCorps Secures $1.7 Million in Series A4 Funding

BOSTON, January 29, 2019 (Newswire.com) - OnCorps, a machine learning company providing decision guidance software to the financial services and technology industries, has secured $1.7 million in Series A financing. The funding is provided by several prominent asset management executives interested in applying machine learning to support asset management decisions. OnCorps helps companies improve decisions by tracking and guiding a team’s decisions then applying machine learning and behavioral science algorithms to improve performance.

This round’s participants include, among others: Churchill Franklin, chairman of Acadian Asset Management, and Joseph (Joe) Dello Russo, former CFO of MFS Investments, who is also a member of the OnCorps Board of Directors.

The Series A4 round brings OnCorps’ total financing to $5.6 million. Prior seed investors include Andreessen Horowitz, the former international chairman of Accenture, the former COO of Bridgewater, a director emeritus from McKinsey and the former CIOs of Merck, Goldman Sachs, Sallie Mae and Fidelity.

OnCorps approaches machine learning differently. Instead of just tapping historic data to make predictions, OnCorps tracks the decisions of a team’s best performers to train its algorithms. OnCorps has developed a unique methodology that integrates machine learning and behavioral science to guide decision-makers as it learns from their observations and actions. The company delivers customized systems in record time for the price of a SaaS subscription.

About OnCorps

OnCorps helps people make better decisions by giving them personalized decision-making tools powered by machine learning and behavioral science algorithms. The platform leverages prominent research in behavioral science to engage users and provide more comprehensive data that will produce better, more actionable decisions. OnCorps serves the largest global financial, consulting and technology firms seeking an edge in decision analytics. For more information, visit www.oncorps.io.

Source: OnCorps